Shopping Cart 0
Cart Subtotal
AED 0

TG Therapeutics Inc (TGTX) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 459

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 918

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 1376
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

TG Therapeutics Inc (TGTX)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

TG Therapeutics Inc (TG Therapeutics) is a biopharmaceutical company which acquires, develops and commercializes pharmaceutical products for the treatment of B-cell malignancies and autoimmune diseases. The company develops two therapies, namely, TG-1101 (ublituximab) and TGR-1202 for the treatment of hematological malignancies. TG-1101 glycoengineered monoclonal antibody that targets a unique epitope on the B-lymphocyte CD20 antigen and TG-1202 is an orally available PI3K delta inhibitor. Its other product candidates include inhibitors of IRAK4 and anti-PD-L1 and anti-GITR antibodies. The company also offers products and technologies for in-licensing, partnership, acquisition and/or investment. TG Therapeutics is headquartered in New York City, New York, the US.

TG Therapeutics Inc Key Recent Developments

Jun 04,2018: TG Therapeutics Names Adam Waldman As Chief Commercial Officer

May 08,2018: TG Therapeutics Provides Business Update and Reports First Quarter 2018 Financial Results

Nov 08,2017: TG Therapeutics Provides Business Update and Reports Third Quarter 2017 Financial Results

Aug 09,2017: TG Therapeutics Provides Business Update and Reports Second Quarter 2017 Financial Results

May 05,2017: TG Therapeutics Provides Business Update and Reports First Quarter 2017 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

TG Therapeutics Inc-Key Facts 5

TG Therapeutics Inc-Key Employees 6

TG Therapeutics Inc-Key Employee Biographies 7

TG Therapeutics Inc-Major Products and Services 8

TG Therapeutics Inc-History 9

TG Therapeutics Inc-Company Statement 11

TG Therapeutics Inc-Locations And Subsidiaries 12

Head Office 12

Other Locations & Subsidiaries 12

Section 2-Company Analysis 13

Company Overview 13

TG Therapeutics Inc-Business Description 14

TG Therapeutics Inc-SWOT Analysis 15

SWOT Analysis-Overview 15

TG Therapeutics Inc-Strengths 15

TG Therapeutics Inc-Weaknesses 16

TG Therapeutics Inc-Opportunities 17

TG Therapeutics Inc-Threats 18

TG Therapeutics Inc-Key Competitors 19

Section 3-Company Financial Ratios 20

Financial Ratios-Capital Market Ratios 20

Financial Ratios-Annual Ratios 21

Performance Chart 23

Financial Performance 23

Financial Ratios-Interim Ratios 24

Financial Ratios-Ratio Charts 25

Section 4-Company's Lifesciences Financial Deals and Alliances 26

TG Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 26

TG Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 27

TG Therapeutics Inc, Recent Deals Summary 28

Section 5-Company's Recent Developments 29

May 08, 2018: TG Therapeutics Provides Business Update and Reports First Quarter 2018 Financial Results 29

Nov 08, 2017: TG Therapeutics Provides Business Update and Reports Third Quarter 2017 Financial Results 30

Aug 09, 2017: TG Therapeutics Provides Business Update and Reports Second Quarter 2017 Financial Results 31

May 05, 2017: TG Therapeutics Provides Business Update and Reports First Quarter 2017 Financial Results 33

Mar 10, 2017: TG Therapeutics Announces Fourth Quarter and Year-End 2016 Financial Results and Business Update 35

Section 6-Appendix 36

Methodology 36

Ratio Definitions 36

About GlobalData 40

Contact Us 40

Disclaimer 40


List Of Figure

List of Figures

TG Therapeutics Inc, Performance Chart (2013-2017) 23

TG Therapeutics Inc, Ratio Charts 25

TG Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 26

TG Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 27


List Of Table

List of Tables

TG Therapeutics Inc, Key Facts 5

TG Therapeutics Inc, Key Employees 6

TG Therapeutics Inc, Key Employee Biographies 7

TG Therapeutics Inc, Major Products and Services 8

TG Therapeutics Inc, History 9

TG Therapeutics Inc, Subsidiaries 12

TG Therapeutics Inc, Key Competitors 19

TG Therapeutics Inc, Ratios based on current share price 20

TG Therapeutics Inc, Annual Ratios 21

TG Therapeutics Inc, Annual Ratios (Cont...1) 22

TG Therapeutics Inc, Interim Ratios 24

TG Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 26

TG Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 27

TG Therapeutics Inc, Recent Deals Summary 28

Currency Codes 36

Capital Market Ratios 36

Equity Ratios 37

Profitability Ratios 37

Cost Ratios 38

Liquidity Ratios 38

Leverage Ratios 39

Efficiency Ratios 39

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

TG Therapeutics Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Infinity Pharmaceuticals Inc

Hoffmann-La Roche Inc

Dr. Reddy's Laboratories Limited

Cyclacel Pharmaceuticals Inc

TG Therapeutics Inc (TGTX)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

TG Therapeutics Inc (TG Therapeutics) is a biopharmaceutical company which acquires, develops and commercializes pharmaceutical products for the treatment of B-cell malignancies and autoimmune diseases. The company develops two therapies, namely, TG-1101 (ublituximab) and TGR-1202 for the treatment of hematological malignancies. TG-1101 glycoengineered monoclonal antibody that targets a unique epitope on the B-lymphocyte CD20 antigen and TG-1202 is an orally available PI3K delta inhibitor. Its other product candidates include inhibitors of IRAK4 and anti-PD-L1 and anti-GITR antibodies. The company also offers products and technologies for in-licensing, partnership, acquisition and/or investment. TG Therapeutics is headquartered in New York City, New York, the US.

TG Therapeutics Inc Key Recent Developments

Jun 04,2018: TG Therapeutics Names Adam Waldman As Chief Commercial Officer

May 08,2018: TG Therapeutics Provides Business Update and Reports First Quarter 2018 Financial Results

Nov 08,2017: TG Therapeutics Provides Business Update and Reports Third Quarter 2017 Financial Results

Aug 09,2017: TG Therapeutics Provides Business Update and Reports Second Quarter 2017 Financial Results

May 05,2017: TG Therapeutics Provides Business Update and Reports First Quarter 2017 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

TG Therapeutics Inc-Key Facts 5

TG Therapeutics Inc-Key Employees 6

TG Therapeutics Inc-Key Employee Biographies 7

TG Therapeutics Inc-Major Products and Services 8

TG Therapeutics Inc-History 9

TG Therapeutics Inc-Company Statement 11

TG Therapeutics Inc-Locations And Subsidiaries 12

Head Office 12

Other Locations & Subsidiaries 12

Section 2-Company Analysis 13

Company Overview 13

TG Therapeutics Inc-Business Description 14

TG Therapeutics Inc-SWOT Analysis 15

SWOT Analysis-Overview 15

TG Therapeutics Inc-Strengths 15

TG Therapeutics Inc-Weaknesses 16

TG Therapeutics Inc-Opportunities 17

TG Therapeutics Inc-Threats 18

TG Therapeutics Inc-Key Competitors 19

Section 3-Company Financial Ratios 20

Financial Ratios-Capital Market Ratios 20

Financial Ratios-Annual Ratios 21

Performance Chart 23

Financial Performance 23

Financial Ratios-Interim Ratios 24

Financial Ratios-Ratio Charts 25

Section 4-Company's Lifesciences Financial Deals and Alliances 26

TG Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 26

TG Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 27

TG Therapeutics Inc, Recent Deals Summary 28

Section 5-Company's Recent Developments 29

May 08, 2018: TG Therapeutics Provides Business Update and Reports First Quarter 2018 Financial Results 29

Nov 08, 2017: TG Therapeutics Provides Business Update and Reports Third Quarter 2017 Financial Results 30

Aug 09, 2017: TG Therapeutics Provides Business Update and Reports Second Quarter 2017 Financial Results 31

May 05, 2017: TG Therapeutics Provides Business Update and Reports First Quarter 2017 Financial Results 33

Mar 10, 2017: TG Therapeutics Announces Fourth Quarter and Year-End 2016 Financial Results and Business Update 35

Section 6-Appendix 36

Methodology 36

Ratio Definitions 36

About GlobalData 40

Contact Us 40

Disclaimer 40


List Of Figure

List of Figures

TG Therapeutics Inc, Performance Chart (2013-2017) 23

TG Therapeutics Inc, Ratio Charts 25

TG Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 26

TG Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 27


List Of Table

List of Tables

TG Therapeutics Inc, Key Facts 5

TG Therapeutics Inc, Key Employees 6

TG Therapeutics Inc, Key Employee Biographies 7

TG Therapeutics Inc, Major Products and Services 8

TG Therapeutics Inc, History 9

TG Therapeutics Inc, Subsidiaries 12

TG Therapeutics Inc, Key Competitors 19

TG Therapeutics Inc, Ratios based on current share price 20

TG Therapeutics Inc, Annual Ratios 21

TG Therapeutics Inc, Annual Ratios (Cont...1) 22

TG Therapeutics Inc, Interim Ratios 24

TG Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 26

TG Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 27

TG Therapeutics Inc, Recent Deals Summary 28

Currency Codes 36

Capital Market Ratios 36

Equity Ratios 37

Profitability Ratios 37

Cost Ratios 38

Liquidity Ratios 38

Leverage Ratios 39

Efficiency Ratios 39

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

TG Therapeutics Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Infinity Pharmaceuticals Inc

Hoffmann-La Roche Inc

Dr. Reddy's Laboratories Limited

Cyclacel Pharmaceuticals Inc